首页 | 本学科首页   官方微博 | 高级检索  
     

RPN2与肝癌患者预后及对肝癌细胞生长的作用
引用本文:答秀维,张 蓓,尚 芸,王 琳,张洪新,赵 超. RPN2与肝癌患者预后及对肝癌细胞生长的作用[J]. 现代生物医学进展, 2020, 0(8): 1425-1430
作者姓名:答秀维  张 蓓  尚 芸  王 琳  张洪新  赵 超
作者单位:空军军医大学第二附属医院 疼痛科 陕西 西安710038;空军军医大学第二附属医院 神经内科 陕西 西安710038
基金项目:国家自然科学基金项目(81772934,81802345)
摘    要:目的:探讨核糖蛋白2(ribophorin II,RPN2)在肝细胞肝癌(HCC)组织中的表达和对HCC患者生存的影响,同时分析RPN2对肝癌HepG2细胞生长和克隆形成的作用。方法:应用免疫组化方法和HCC公共芯片数据,从蛋白和m RNA水平检测HCC组织中RPN2的表达,同时分析RPN2与HCC患者临床参数的关系及预后相关性;进一步利用MTS法和克隆形成实验在肝癌HepG2细胞中检测RPN2对细胞生长的作用。结果:98例肝癌组织中,RPN2阳性表达率88.78%,对应癌旁肝组织中,RPN2阳性表达率74.49%;癌组织中RPN2染色评分为5.80±3.15,癌旁肝组织RPN2染色评分为2.13±1.59,肝癌组织中RPN2表达显著上调(P0.001)。3个肝癌公共芯片数据(共522例肝癌)中RPN2的m RNA表达水平同样显著升高(均P0.001)。98例肝癌患者RPN2表达水平与肿瘤直径(P=0.004)、门脉侵袭(P=0.012)和TNM分期(P=0.009)相关;RPN2高表达的患者总体生存期(OS)和无复发生存期(RFS)较RPN2低表达的患者短(OS:P=0.027;RFS:P=0.036)。肝癌HepG2细胞转染RPN2小干扰RNA后,细胞生长能力显著受抑制。结论:RPN2在肝癌中表达显著升高,RPN2的表达与肝癌的恶性进展有关,RPN2显著促进肝癌细胞生长。

关 键 词:RPN2;预后;生长;肝细胞肝癌
收稿时间:2019-11-29
修稿时间:2019-12-25

Prognostic Value of RPN2 in Hepatocellular Carcinoma and Its Effect on the Growth of Hepatocellular Carcinoma Cells
DA Xiu-wei,ZHANG Bei,SHANG Yun,WANG Lin,ZHANG Hong-xin,ZHAO Chao. Prognostic Value of RPN2 in Hepatocellular Carcinoma and Its Effect on the Growth of Hepatocellular Carcinoma Cells[J]. Progress in Modern Biomedicine, 2020, 0(8): 1425-1430
Authors:DA Xiu-wei  ZHANG Bei  SHANG Yun  WANG Lin  ZHANG Hong-xin  ZHAO Chao
Affiliation:Departement of Pain Treatment, Second Affiliated Hospital, the Fourth Military Medical University, Xi''an, Shaanxi, 710038, China; Departement of Neurology, Second Affiliated Hospital, the Fourth Military Medical University, Xi''an, Shaanxi, 710038, China
Abstract:ABSTRACT Objective: To explore the expression of Ribophorin II (RPN2) in hepatocellular carcinoma (HCC) and its effect on the survival of HCC patients, and to analyze the effects of RPN2 on the growth of HepG2 cells. Methods: The protein and mRNA expression of RPN2 in HCC patients was analyzed by immunohistochemical (IHC) staining and public data of HCC, and to analyze its relationship between the expression of RPN2 and clinicopathological features and prognosis of HCC patients. The effects of RPN2 on the growth of HCC cells were detected by using MTS and cloning formation experiment in HepG2 cells. Results: In 98 HCC tissues, the RPN2 positive expression rate was 88.78%, and the RPN2 positive expression rate was 74.49% in the para-carcinoma tissue. The RPN2 staining score was 5.80±3.15 in HCC tissue, and the RPN2 staining score was 2.13±1.59 in the para-carcinoma tissue, the expression of RPN2 in HCC was significantly increased (P<0.001). The expression of RPN2 mRNA in three public data of HCC (522 cases) was also significantly increased (All P<0.001). RPN2 expression was related to tumor diameter (P=0.004), portal vein invasion (P=0.012) and TNM staging (P=0.009) in 98 HCC patients. The overall survival (OS) and recurrence-free survival (RFS) of HCC patients with high expression of RPN2 were shorter than those with RPN2 low expression (OS: P=0.027; RFS: P=0.036). The cell growth was significantly inhibited with the transfection of RPN2 siRNA in HepG2 cells. Conclusion: The expression of RPN2 in HCC was significantly increased, and the expression of RPN2 was related to the progression of HCC. RPN2 promoted HCC cell growth.
Keywords:RPN2   Prognosis   Growth   HCC
本文献已被 CNKI 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号